Optimal use of clotting factors and immunoglobulins
The symposium “Optimal use of clotting factors and immunoglobulins” was held on 26 and 27 April 2013 in Wildbad Kreuth (Germany) in the tradition of two previous symposia held in the same place. The first symposium in 1999, “Blood safety in the European Community: An initiative for optimal use” provided the basis for discussion. The second symposium, held in 2009, on “Optimal clinical use of blood components” took the topic further for a variety of blood components. The 2013 symposium focused on clotting factors and immunoglobulins. This latter topic had not been included in the previous symposia. The recommendations established at the 1999 and 2009 Kreuth symposia were very well received in the field and were promoted by patient and medical organisations. They were considered useful by public health authorities in helping to pursue best practices in transfusion medicine, as well as in treatments using plasma-derived medicinal products.
– select item….add to cart…view cart….fill your information…submit then check your mail